These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15336530)

  • 1. The solubility and stability of recombinant proteins are increased by their fusion to NusA.
    De Marco V; Stier G; Blandin S; de Marco A
    Biochem Biophys Res Commun; 2004 Sep; 322(3):766-71. PubMed ID: 15336530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New fusion protein systems designed to give soluble expression in Escherichia coli.
    Davis GD; Elisee C; Newham DM; Harrison RG
    Biotechnol Bioeng; 1999 Nov; 65(4):382-8. PubMed ID: 10506413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-step metal affinity purification of double-tagged (NusA-His6) fusion proteins.
    de Marco A
    Nat Protoc; 2006; 1(3):1538-43. PubMed ID: 17406446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble expression of archaeal proteins in Escherichia coli by using fusion-partners.
    Kim S; Lee SB
    Protein Expr Purif; 2008 Nov; 62(1):116-9. PubMed ID: 18657619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners.
    Nallamsetty S; Waugh DS
    Protein Expr Purif; 2006 Jan; 45(1):175-82. PubMed ID: 16168669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level soluble production of functional ribonuclease inhibitor in Escherichia coli by fusing it to soluble partners.
    Guo W; Cao L; Jia Z; Wu G; Li T; Lu F; Lu Z
    Protein Expr Purif; 2011 Jun; 77(2):185-92. PubMed ID: 21292012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of solubility-enhancing fusion proteins and organic solvents on the in vitro biocatalytic performance of the carotenoid cleavage dioxygenase AtCCD1 in a micellar reaction system.
    Schilling M; Patett F; Schwab W; Schrader J
    Appl Microbiol Biotechnol; 2007 Jun; 75(4):829-36. PubMed ID: 17333174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of fusion partners for high yield expression and purification of bioactive viscotoxins.
    Bogomolovas J; Simon B; Sattler M; Stier G
    Protein Expr Purif; 2009 Mar; 64(1):16-23. PubMed ID: 18983922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble expression, purification, and characterization of Gloydius shedaoensis venom gloshedobin in Escherichia coli by using fusion partners.
    Jiang X; Xu J; Yang Q
    Appl Microbiol Biotechnol; 2010 Jan; 85(3):635-42. PubMed ID: 19639313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A favorable solubility partner for the recombinant expression of streptavidin.
    Sørensen HP; Sperling-Petersen HU; Mortensen KK
    Protein Expr Purif; 2003 Dec; 32(2):252-9. PubMed ID: 14965771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized expression of soluble cyclomaltodextrinase of thermophilic origin in Escherichia coli by using a soluble fusion-tag and by tuning of inducer concentration.
    Turner P; Holst O; Karlsson EN
    Protein Expr Purif; 2005 Jan; 39(1):54-60. PubMed ID: 15596360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving solubility of Shewanella oneidensis MR-1 and Clostridium thermocellum JW-20 proteins expressed into Esherichia coli.
    Kataeva I; Chang J; Xu H; Luan CH; Zhou J; Uversky VN; Lin D; Horanyi P; Liu ZJ; Ljungdahl LG; Rose J; Luo M; Wang BC
    J Proteome Res; 2005; 4(6):1942-51. PubMed ID: 16335938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual expression system suitable for high-throughput fluorescence-based screening and production of soluble proteins.
    Braud S; Moutiez M; Belin P; Abello N; Drevet P; Zinn-Justin S; Courçon M; Masson C; Dassa J; Charbonnier JB; Boulain JC; Ménez A; Genet R; Gondry M
    J Proteome Res; 2005; 4(6):2137-47. PubMed ID: 16335960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced fit of passenger proteins fused to Archaea maltose binding proteins.
    Huang H; Liu J; de Marco A
    Biochem Biophys Res Commun; 2006 May; 344(1):25-9. PubMed ID: 16615999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, purification of human vasostatin120-180 in Escherichia coli, and its anti-angiogenic characterization.
    Sun QM; Cao L; Fang L; Chen C; Dai J; Chen LL; Hua ZC
    Protein Expr Purif; 2005 Feb; 39(2):288-95. PubMed ID: 15642481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HaloTag7: a genetically engineered tag that enhances bacterial expression of soluble proteins and improves protein purification.
    Ohana RF; Encell LP; Zhao K; Simpson D; Slater MR; Urh M; Wood KV
    Protein Expr Purif; 2009 Nov; 68(1):110-20. PubMed ID: 19464373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pCold-GST vector: a novel cold-shock vector containing GST tag for soluble protein production.
    Hayashi K; Kojima C
    Protein Expr Purif; 2008 Nov; 62(1):120-7. PubMed ID: 18694833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modular set of prokaryotic and eukaryotic expression vectors.
    Melcher K
    Anal Biochem; 2000 Jan; 277(1):109-20. PubMed ID: 10610695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies.
    Sun W; Xie J; Lin H; Mi S; Li Z; Hua F; Hu Z
    Protein Expr Purif; 2012 May; 83(1):21-9. PubMed ID: 22387083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled intracellular processing of fusion proteins by TEV protease.
    Kapust RB; Waugh DS
    Protein Expr Purif; 2000 Jul; 19(2):312-8. PubMed ID: 10873547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.